Monitoring early tumor response to drug therapy with diffuse optical tomography.
暂无分享,去创建一个
Molly L Flexman | Andreas H Hielscher | Mark A Borden | Hyun Keol Kim | Jianzhong Huang | A. Hielscher | Antai Wang | Jianzhong Huang | D. Yamashiro | J. Kandel | S. Sirsi | M. Borden | S. Hernandez | Tessa B. Johung | Jeffrey W. Gander | Ari R. Reichstein | Antai Wang | Fotios Vlachos | Shashank R Sirsi | Sonia L Hernandez | Tessa B Johung | Jeffrey W Gander | Ari R Reichstein | Brooke S Lampl | Darrell J Yamashiro | Jessica J Kandel | H. K. Kim | M. Flexman | B. Lampl | F. Vlachos
[1] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[2] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[3] Geert Molenberghs,et al. Random Effects Models for Longitudinal Data , 2010 .
[4] T. Brown,et al. Longitudinal mapping of mouse cerebral blood volume with MRI , 2006, NMR in biomedicine.
[5] Martin H. Teicher,et al. Brain T2 relaxation times correlate with regional cerebral blood volume , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.
[6] R. Edelman,et al. Clinical magnetic resonance imaging , 1990 .
[7] Wolfhard Semmler,et al. Assessment of vascular remodeling under antiangiogenic therapy using DCE‐MRI and vessel size imaging , 2009, Journal of magnetic resonance imaging : JMRI.
[8] D. Yamashiro,et al. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[9] Kevin Girtman,et al. SK‐NEP‐1 and Rh1 are Ewing family tumor lines , 2008, Pediatric blood & cancer.
[10] Eugene S. Kim,et al. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] Ma Dong,et al. Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .
[12] Joseph M. Lasker. A digital-signal-processor-based optical tomographic system for dynamic imaging of joint diseases , 2008 .
[13] J. Spratlin,et al. The role of bevacizumab in colorectal cancer: understanding its benefits and limitations , 2011, Expert opinion on biological therapy.
[14] David A Boas,et al. Assessing the future of diffuse optical imaging technologies for breast cancer management. , 2008, Medical physics.
[15] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[16] Thorsten Persigehl,et al. Optical techniques for the molecular imaging of angiogenesis , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[17] Jianzhong Huang,et al. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[19] A. Griffioen,et al. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. , 2000, Microvascular research.
[20] Xiaoyuan Chen,et al. PET Imaging of Angiogenesis. , 2009, PET clinics.
[21] Andreas H. Hielscher,et al. PDE-constrained multispectral imaging of tissue chromophores with the equation of radiative transfer , 2010, Biomedical optics express.
[22] Ludguier D. Montejo,et al. Frequency-Domain Optical Tomography of Arthritic Joints , 2010 .
[23] J Folkman,et al. Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.
[24] F. Kabbinavar,et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] K. Schmainda,et al. Multimodality Imaging of Abnormal Vascular Perfusion and Morphology in Preclinical 9L Gliosarcoma Model , 2011, PloS one.
[26] A. Yodh,et al. Direct measurement of tissue blood flow and metabolism with diffuse optics , 2011, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[27] Perry F. Renshaw,et al. Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry , 2000, Nature Medicine.
[28] S. L. Bridal,et al. Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives. , 2010, Critical reviews in oncology/hematology.
[29] A. Heerschap,et al. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI , 2008, British Journal of Cancer.
[30] Gabriele Bergers,et al. Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.
[31] C. Stolar,et al. Suppression of primary tumor growth in a mouse model of human neuroblastoma. , 2000, Journal of pediatric surgery.
[32] J. Penfield. Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents , 2008, Pediatric Nephrology.
[33] A. Troxel,et al. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor. , 2000, Journal of pediatric surgery.
[34] Wensheng Guo,et al. Computer aided automatic detection of malignant lesions in diffuse optical mammography. , 2010, Medical physics.
[35] W. Heindel,et al. Concurrent MR blood volume and vessel size estimation in tumors by robust and simultaneous ΔR2 and ΔR2* quantification , 2011, Magnetic resonance in medicine.
[36] Eugene S. Kim,et al. TNP-470 promotes initial vascular sprouting in xenograft tumors. , 2004, Molecular cancer therapeutics.
[37] W. Eric L. Grimson,et al. Anatomical atlas-guided diffuse optical tomography of brain activation , 2009, NeuroImage.
[38] Kevin M. Johnson,et al. Gadolinium‐bearing red cells as blood pool MRI contrast agents , 1998, Magnetic resonance in medicine.